Limitations and late complications of third-generation automatic cardioverter-defibrillators

Circulation

Volumn 91, Issue 8, 1995, Pages 2204-2213

  Nunain, S O ^a   Roelke, M ^a   Trouton, T ^a   Osswald, S ^a   Kim, Y H ^a   Sosa Suarez, G ^a   Brooks, D R ^a   McGovern, B ^a   Guy, M ^a   Torchiana, D F ^a   Vlahakes, G J ^a   Garan, H ^a   Ruskin, J N ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MEDTRONIC INC   (United States)

Author keywords

arrhythmia; defibrillation; defibrillators; pacing

Indexed keywords

ADULT; AGED; ARTICLE; BRADYCARDIA; DEFIBRILLATION; DEFIBRILLATOR; ELECTRIC SHOCK; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE PACING; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULSE GENERATOR; SINUS TACHYCARDIA; SURGICAL MORTALITY; TACHYCARDIA;

EID: 0028948140     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.91.8.2204     Document Type: Article

References (25)

1. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SE, Fischell RE, Weisfeldt ML. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303:322-324.
2. Kelly PA, Cannom DS, Garan H, Mirabal GS, Harthorne JW, Hurvitz RJ, Vlahakes GJ, Jacobs ML, Ilvento JP, Buckley MJ, Ruskin JN. The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol. 1988;11:1278-1286.
3. Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WA, Schmidt P, Shipman T. Long-term outcome with the automatic implantable cardioverter defibrillator. J Am Coll Cardiol. 1989;13: 1353-1361.
4. Kim SG. Management of survivors of cardiac arrest: is electrophysiologic testing obsolete in the era of implantable defibrillators? J Am Coll Cardiol. 1990;16:756-761.
5. Hurwitz JL, Hook BG, Flores BT, Marchlinski FE. Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices. J Am Coll Cardiol. 1993;21:895-900.
6. Bardy GH, Hofer B, Johnson G, Kudenchuk PJ, Poole JE, Dolack L, Gleva M, Mitchell R, Kelso D. Implantable transvenous cardioverter-defibrillators. Circulation. 1993;87:1152-1168.
7. Yee R, Klein GJ, Leitch JW, Guiraudon GM, Guiraudon CM, Jones DL, Norris C. A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator: nonthoracotomy approach to implantation. Circulation. 1992;85:196-204.
8. Jordaens L, Trouerbach J-W, Vertongen P, Herregods L, Polaert J, Van Nooten G. Experience of cardioverter-defibrillators inserted without thoracotomy: evaluation of transvenously inserted intracardiac leads alone or with a subcutaneous axillary patch. Br Heart J. 1993;69:14-19.
9. Saksena S, Mehta D, Krol RB, Tullo NG, Saxena A, Kaushik R, Neglia J. Experience with a third-generation implantable cardioverter-defibrillator. Am J Cardiol. 1991;67:1375-1384.
10. Fromer M, Brachmann J, Block M, Siebels J, Hoffmann E, Almendral J, Ohm OJ, den Dulk K, Coumel P, Camm AJ, Toubol P. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator: results of a European multicenter study of 102 implants. Circulation. 1992;86:363-374.
11. Bardy GH, Troutman C, Poole JE, Kudenchuk PJ, Dolack GL, Johnson G, Hofer B. Clinical experience with a tiered therapy, multiprogrammable antiarrhythmia device. Circulation. 1992;85: 1689-1698.
12. Marchlinski FE, Gottlieb CD, Sarter B, Finkle J, Hook B, Callans D, Schwartzman D. ICD data storage: value in arrhythmia management. PACE Pacing Clin Electrophysiol. 1993;16(pt II):527-534.
13. Saksena S, Huanlin A, Mehra R, DeGroot P, Krol RS, Burkhardt E, Mehta D, John T. Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads. Am J Cardiol. 1992;70:304-310.
14. Kim SG, Fisher JD, Furman S, Gross J, Zilo P, Roth JA, Ferrick KJ, Brodman R. Exacerbation of ventricular arrhythmias during the postoperative period after implantation of an automatic defibrillator. J Am Coll Cardiol. 1991;18:1200-1206.
15. Johnson NJ, Marchlinski FE. Arrhythmias induced by device antitachycardia therapy due to diagnostic nonspecificity. J Am Coll Cardiol. 1991;18:1418-1425.
16. Callans DJ, Hook BG, Marchlinski FE. Paced beats following single nonsensed complexes in a 'codependent' cardioverter defibrillator and bradycardia pacing system: potential for ventricular tachycardia induction. PACE Pacing Clin Electrophysiol. 1991;14:1281-1287.
17. Bardy GH, Johnson G, Poole JE, Dolack L, Kudenchuk PJ, Kelso D, Mitchell R, Mehra R, Hofer B. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation. 1993; 88:543-547.
18. Grimm W, Flores BF, Marchlinski FE. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. PACE Pacing Clin Electrophysiol. 1992;15:1667-1673.
19. Grimm W, Flores BF, Marchlinski FE. Complications of implantable cardioverter defibrillator therapy: follow-up of 241 patients. PACE Pacing Clin Electrophysiol. 1993;16:218-222.
20. Paul VE, Anderson M, Jones S, Skehan DJ, Camm AJ, Ward DE. Cardiologist implanted cardioverter defibrillators: early experience of three systems. Eur J Cardiac Pacing Electrophysiol. 1991;1:21-26.
21. Tullo NG, Saksena S, Krol RB, Mauro AM, Kunecz D. Management of complications associated with a first generation endocardial defibrillation lead system for implantable cardioverter defibrillators. Am J Cardiol. 1990;66:411-415.
22. Luu M, Stevenson WG, Stevenson LW, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 1989;80:1675-1680.
23. Packer M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation. 1992;85(suppl I):I-50-I-56.
24. Porterfield JG, Porterfield LM, Smith BA, Bray L. Experience with three different third generation cardioverter-defibrillators in patients with coronary artery disease or cardiomyopathy. Am J Cardiol. 1993;72:301-304.
25. Leitch JW, Gillis AM, Wyse G, Yee R, Klein GJ, Guiraudon G, Sheldon RS, Duff HJ, Kieser TM, Mitchell LB. Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy. J Am Coll Cardiol. 1991;18:145-151.